Edwards Lifesciences Corp (EW)

traders view logo Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Edwards Lifesciences Corp (EW) Profile

Market Cap 79.846B USD Sector(s): Healthcare Industry: Medical Devices Full-Time Employees: 14,900 (2020) Edwards Lifesciences total assets for the quarter ending September 30, 2021, were $8.160B, a 19.99% increase year-over-year.

Edwards Lifesciences Corporation makes and sells products and technologies for structural heart disease, critical care, and surgical monitoring in the United States, Europe, Japan, and other places around the world. It sells heart valve replacement products that don't require a lot of surgery. It also sells heart valve repair and replacement products to treat mitral and tricuspid valve problems. Additionally, the company offers surgical heart valve therapy products, including pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; and a beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors.

Edwards Lifesciences Corp (EW.xnys) News; Critical Care – Edwards plans to drive growth and leadership with innovations in critical care technologies, with the goal of improving care for 20 million patients annually. The company is currently integrating a full range of Smart Recovery technologies on the HemoSphere monitoring platform that will create a unique offering of enhanced recovery tools to further strengthen the company’s leadership in smart monitoring. Furthermore, in 2022, Edwards anticipates the U.S. launch of its Viewfinder network connectivity solution and the initiation of the SMART BP study. Edwards believes the global hemodynamic monitoring market opportunity will reach approximately $2 billion by 2028.

December 20, 2021 IRVINE, Calif., Dec. 20, 2021 /PRNew swire Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive present (SAPIEN 3 with Alterra) for patients with severe pulmonary regurgitation.

Holding cost
Trading hours in US Eastern Time
10:00 - 18:30
10:00 - 18:30
10:00 - 18:30
10:00 - 18:30
10:00 - 18:30

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

Why Trade Edwards Lifesciences Corp (EW.xnys) with FP Markets? An Australian-regulated forex & CFD broker
go long or short
Go Long or Short

Increase your ability to profit in
all market conditions
Leverage options up to 20:1

direct market access
Direct Market Access (DMA) Execution

Real-time, transparent share prices
Control, Functionality and deep liquidity
Full Market depth & see your orders in the queue

advanced platforms
Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with
superior client portal

24/5 Multilingual customer support
24/5 Multilingual
Customer Support

Award winning support &
personal account managers

global exposure
Global Exposure

Low margins and competitive commission
+10,000 products on global stocks
across 4 continents

earn dividends
Earn Dividends

On long positions
No ownership of physical
shares necessary

Bắt Đầu Giao Dịch sau một vài phút

bullet Truy cập trên 10.000 công cụ tài chính
bullet Tự động mở & đóng vị thế
bullet Lịch sự kiện tin tức & kinh tế
bullet Chỉ báo & biểu đồ kỹ thuật
bullet Bao gồm nhiều công cụ hơn

Bằng việc cung cấp email của mình, bạn đồng ý với chính sách về quyền riêng tư của FP Markets và nhận các tài liệu marketing trong tương lai từ FP Markets. Bạn có thể hủy đăng ký bất cứ lúc nào.

Source - database | Page ID - 16879

Get instant Updates in Telegram